CDCP1 and renal cell carcinoma: Moreover, our immunohistochemical findings further revealed significantly increased expressions of CDCP1 and t-PA in OSCC, which correspond with CDCP1 overexpression in renal cell carcinoma[22] and in lung adenocarcinoma [23] and with t-PA overexpression in lung cancer [24].